The emerging picture of autism spectrum disorder: Genetics and pathology

Annual Review of Pathology: Mechanisms of Disease

Volumn 10, Issue , 2015, Pages 111-144

  Chen, Jason A ^a   Peñagarikano, Olga ^b   Belgard, T Grant ^c   Swarup, Vivek ^a   Geschwind, Daniel H ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

human genetics; molecular pathology; mouse models; neuropathology; systems biology

Indexed keywords

OXYTOCIN; SEROTONIN; VASOPRESSIN;

ARTICLE; AUTISM; BRAIN CORTEX; BRAIN STEM; CEREBELLUM; CHROMATIN STRUCTURE; CLINICAL FEATURE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC VARIABILITY; GENOTYPE; GLIA CELL; HEREDITY; HUMAN; HUMAN GENETICS; LIMBIC SYSTEM; MONOZYGOTIC TWINS; NEUROPATHOLOGY; NEUROTRANSMISSION; NEXT GENERATION SEQUENCING; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL INTERACTION; SYNAPSE; TRANSCRIPTOMICS; ANIMAL; DISEASE MODEL; GENETICS; MOUSE; PATHOLOGY;

ANIMALS; CHILD DEVELOPMENT DISORDERS, PERVASIVE; DISEASE MODELS, ANIMAL; HUMANS; MICE;

EID: 84921917284     PISSN: 15534006     EISSN: 15534014     Source Type: Book Series    
DOI: 10.1146/annurev-pathol-012414-040405     Document Type: Article

References (256)

1. Am. Psychiatr. Assoc. 2013. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: Am. Psychiatr. Publ. 5th ed.
2. Autism Dev. Disabil. Monit. Netw. Surveill. Year 2010 Princ. Investig. 2014. Prevalence of autism spectrum disorder among children aged 8 years-Autism and developmental disabilities monitoring network, 11 sites, United States, 2010. Morb. Mortal. Wkly. Rep. 63:1-21
3. Kanner L. 1943. Autistic disturbances of affective contact. Nervous Child 2:217-50
4. Lord C, Petkova E, Hus V, Gan W, Lu F, et al. 2012. A multisite study of the clinical diagnosis of different autism spectrum disorders. Arch. Gen. Psychiatry 69:306-13
5. McCracken JT, McGough J, Shah B, Cronin P, HongD, et al. 2002. Risperidone in children with autism and serious behavioral problems. N. Engl. J. Med. 347:314-21
6. Wing L. 2000. Past and future of research on Asperger syndrome. In Asperger Syndrome, ed. A Klin, FR Volkmar, SS Sparrow, pp. 418-32. New York: Guilford
7. Kolevzon A, Smith CJ, Schmeidler J, Buxbaum JD, Silverman JM. 2004. Familial symptom domains in monozygotic siblings with autism. Am. J. Med. Genet. B 129B:76-81
8. Daniels A, Rosenberg R, Law JK, Lord C, Kaufmann W, Law P. 2011. Stability of initial autism spectrum disorder diagnoses in community settings. J. Autism Dev. Disord. 41:110-21
9. Berg J, Geschwind D. 2012. Autism genetics: searching for specificity and convergence. Genome Biol. 13:1-16
10. Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, et al. 2007. The epidemiology of autism spectrum disorders. Annu. Rev. Public Health 28:235-58
11. Christensen J, Gronborg T, Sorensen M, Schendel D, Parner ET, et al. 2013. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309:1696-703
12. Lowe TL, Tanaka K, Seashore MR, Young J, Cohen DJ. 1980. Detection of phenylketonuria in autistic and psychotic children. JAMA 243:126-28
13. Novarino G, El-Fishawy P, Kayserili H, Meguid NA, Scott EM, et al. 2012. Mutations in BCKD-kinase lead to a potentially treatable form of autism with epilepsy. Science 338:394-97
14. Abrahams BS, Geschwind DH. 2008. Advances in autism genetics: on the threshold of a new neurobiology. Nat. Rev. Genet. 9:341-55
15. Strauss KA, Puffenberger EG, Huentelman MJ, Gottlieb S, Dobrin SE, et al. 2006. Recessive symptomatic focal epilepsy and mutant contactin-Associated protein-like 2. N. Engl. J. Med. 354:1370-77
16. Helsmoortel C, Vulto-van Silfhout AT, Coe BP, Vandeweyer G, Rooms L, et al. 2014. A SWI/SNFrelated autism syndrome caused by de novo mutations in ADNP. Nat. Genet. 46:380-84
17. Ozonoff S, Young GS, Carter A, Messinger D, Yirmiya N, et al. 2011. Recurrence risk for autism spectrum disorders: a Baby Siblings Research Consortium study. Pediatrics 128:e488-95
18. Rosenberg RE, Law J, Yenokyan G, McGready J, Kaufmann WE, Law PA. 2009. Characteristics and concordance of autism spectrum disorders among 277 twin pairs. Arch. Pediatr. Adolesc.Med. 163:907-14
19. Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, et al. 2011. Genetic heritability and shared environmental factors among twin pairs with autism. Arch. Gen. Psychiatry 68:1095-102
20. Bailey A, Le Couteur A, Gottesman I, Bolton P, Simonoff E, et al. 1995. Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25:63-77
21. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, et al. 2009. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 459:528-33
22. Ma D, Salyakina D, Jaworski JM, Konidari I, Whitehead PL, et al. 2009. A genome-wide association study of autism reveals a common novel risk locus at 5p14.1. Ann. Hum. Genet. 73:263-73
23. Weiss LA, Arking DE, Gene Discov. Proj. Johns Hopkins, Autism Consort. 2009. A genome-wide linkage and association scan reveals novel loci for autism. Nature 461:802-8
24. Anney R, Klei L, Pinto D, Almeida J, Bacchelli E, et al. 2012. Individual common variants exert weak effects on the risk for autism spectrum disorders. Hum. Mol. Genet. 21:4781-92
25. Anney R, Klei L, Pinto D, Regan R, Conroy J, et al. 2010. A genome-wide scan for common alleles affecting risk for autism. Hum. Mol. Genet. 19:4072-82
26. Klei L, Sanders S, Murtha M, Hus V, Lowe J, et al. 2012. Common genetic variants, acting additively, are a major source of risk for autism. Mol. Autism 3:9
27. Stein JL, Parikshak NN, Geschwind DH. 2013. Rare inherited variation in autism: beginning to see the forest and a few trees. Neuron 77:209-11
28. Cross-Disord.Group Psychiatr. Genomics Consort. 2013. Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat. Genet. 45:984-94
29. Curran S, Bolton P, Rozsnyai K, Chiocchetti A, Klauck SM, et al. 2011. No association between a common single nucleotide polymorphism, rs4141463, in the MACROD2 gene and autism spectrum disorder. Am. J. Med. Genet. B 156:633-39
30. Voight BF, Scott LJ, Steinthorsdottir V, Morris AP, Dina C, et al. 2010. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat. Genet. 42:579-89
31. Ripke S, O'Dushlaine C, Chambert K, Moran JL, Kahler AK, et al. 2013. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45:1150-59
32. Stone JL, Merriman B, Cantor RM, Geschwind DH, Nelson SF. 2007. High density SNP association study of a major autism linkage region on chromosome 17. Hum. Mol. Genet. 16:704-15
33. Alarc on M, Abrahams BS, Stone JL, Duvall JA, Perederiy JV, et al. 2008. Linkage, association, and geneexpression analyses identify CNTNAP2 as an autism-susceptibility gene. Am. J. Hum. Genet. 82:150-59
34. Strom SP, Stone JL, Ten Bosch JR, Merriman B, Cantor RM, et al. 2010. High-density SNP association study of the 17q21 chromosomal region linked to autism identifies CACNA1G as a novel candidate gene. Mol. Psychiatry 15:996-1005
35. Zhao X, Leotta A, Kustanovich V, Lajonchere C, Geschwind DH, et al. 2007. A unified genetic theory for sporadic and inherited autism. PNAS 104:12831-36
36. Kenny EM, Cormican P, Furlong S, Heron E, Kenny G, et al. 2014. Excess of rare novel loss-of-function variants in synaptic genes in schizophrenia and autism spectrum disorders. Mol. Psychiatry 19:872-79
37. Cukier H, Dueker N, Slifer S, Lee J, Whitehead P, et al. 2014. Exome sequencing of extended families with autism reveals genes shared across neurodevelopmental and neuropsychiatric disorders. Mol. Autism 5:1
38. Toma C, Torrico B, Hervas A, Valdes-Mas R, Tristan-Noguero A, et al. 2014. Exome sequencing in multiplex autism families suggests a major role for heterozygous truncating mutations. Mol. Psychiatry 19:784-90
39. Morrow EM, Yoo SY, Flavell SW, Kim TK, Lin Y, et al. 2008. Identifying autism loci and genes by tracing recent shared ancestry. Science 321:218-23
40. Nava C, Lamari F, Heron D, Mignot C, Rastetter A, et al. 2012. Analysis of the chromosome X exome in patients with autism spectrum disorders identified novel candidate genes, including TMLHE. Transl. Psychiatry 2:e179
41. Yu TW, Chahrour MH, Coulter ME, Jiralerspong S, Okamura-Ikeda K, et al. 2013. Using whole-exome sequencing to identify inherited causes of autism. Neuron 77:259-73
42. Lim ET, Raychaudhuri S, Sanders SJ, Stevens C, Sabo A, et al. 2013. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 77:235-42
43. Vissers LELM, de Ligt J, Gilissen C, Janssen I, Steehouwer M, et al. 2010. A de novo paradigm for mental retardation. Nat. Genet. 42:1109-12
44. Fischbach GD, Lord C. 2010. The Simons Simplex Collection: a resource for identification of autism genetic risk factors. Neuron 68:192-95
45. Bundey S, Hardy C, Vickers S, Kilpatrick M, Corbett J. 1994. Duplication of the 15q1113 region in a patient with autism, epilepsy and ataxia. Dev. Med. Child Neurol. 36:736-42
46. Kozma C. 1998. On cognitive variability in velocardiofacial syndrome: profound mental retardation and autism. Am. J. Med. Genet. 81:269-70
47. Thomas NS, Sharp AJ, Browne CE, Skuse D, Hardie C, Dennis NR. 1999. Xp deletions associated with autism in three females. Hum. Genet. 104:43-48
48. Lauritsen M, Mors O, Mortensen P, Ewald H. 1999. Infantile autism and associated autosomal chromosome abnormalities: a register based study and a literature survey. J. Child Psychol. Psychiatry 40:335-45
49. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, et al. 2003. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34:27-29
50. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, et al. 2007. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat. Genet. 39:25-27
51. Levy D, Ronemus M, Yamrom B, Lee Y, Leotta A, et al. 2011. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70:886-97
52. Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, et al. 2007. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 39:319-28
53. Sanders SJ, Ercan-Sencicek AG, Hus V, Luo R, Murtha MT, et al. 2011. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 70:863-85
54. Itsara A, Wu H, Smith JD, Nickerson DA, Romieu I, et al. 2010. De novo rates and selection of large copy number variation. Genome Res. 20:1469-81
55. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, et al. 2007. Strong association of de novo copy number mutations with autism. Science 316:445-49
56. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, et al. 2010. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 466:368-72
57. Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, et al. 2008. Structural variation of chromosomes in autism spectrum disorder. Am. J. Hum. Genet. 82:477-88
58. Sanders SJ, Murtha MT, Gupta AR, Murdoch JD, Raubeson MJ, et al. 2012. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485:237-41
59. Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, et al. 2008. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358:667-75
60. Sun JX, Helgason A, Masson G, Ebenesersdottir SS, Li H, et al. 2012. A direct characterization of human mutation based on microsatellites. Nat. Genet. 44:1161-65
61. Kong A, Frigge ML, Masson G, Besenbacher S, Sulem P, et al. 2012. Rate of de novo mutations and the importance of father's age to disease risk. Nature 488:471-75
62. Campbell CD, Chong JX, Malig M, Ko A, Dumont BL, et al. 2012. Estimating the human mutation rate using autozygosity in a founder population. Nat. Genet. 44:1277-81
63. Michaelson JJ, Shi Y, Gujral M, Zheng H, Malhotra D, et al. 2012. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 151:1431-42
64. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, et al. 2012. De novo gene disruptions in children on the autistic spectrum. Neuron 74:285-99
65. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, et al. 2012. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 485:246-50
66. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, et al. 2012. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 485:242-45
67. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, et al. 2012. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338:1619-22
68. Werling D, Lowe J, Luo R, Cantor R, Geschwind D. 2014. Replication of linkage at chromosome 20p13 and identification of suggestive sex-differential risk loci for autism spectrum disorder. Mol. Autism 5:13
69. Martin-Ruiz CM, Lee M, Perry RH, Baumann M, Court JA, Perry EK. 2004. Molecular analysis of nicotinic receptor expression in autism. Mol. Brain Res. 123:81-90
70. Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, et al. 2005. Reelin signaling is impaired in autism. Biol. Psychiatry 57:777-87
71. Purcell A, Jeon O, Zimmerman A, Blue M, Pevsner J. 2001. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57:1618-28
72. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, et al. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380-84
73. Zikopoulos B, Barbas H. 2010. Changes in prefrontal axons may disrupt the network in autism. J. Neurosci. 30:14595-609
74. Garbett K, Ebert PJ, Mitchell A, Lintas C, Manzi B, et al. 2008. Immune transcriptome alterations in the temporal cortex of subjects with autism. Neurobiol. Dis. 30:303-11
75. Fatemi SH, Halt AR, Stary JM, Kanodia R, Schulz SC, Realmuto GR. 2002. Glutamic acid decarboxylase 65 and 67 a proteins are reduced in autistic parietal and cerebellar cortices. Biol. Psychiatry 52:805-10
76. Yip J, Soghomonian JJ, Blatt G. 2007. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol. 113:559-68
77. Laurence JA, Fatemi SH. 2005. Glial fibrillary acidic protein is elevated in superior frontal, parietal and cerebellar cortices of autistic subjects. Cerebellum 4:206-10
78. Chow ML, Pramparo T, Winn ME, Barnes CC, Li HR, et al. 2012. Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages. PLOS Genet. 8:e1002592
79. Courchesne E, Mouton PR, Calhoun ME, Semendeferi K, Ahrens-Barbeau C, et al. 2011. Neuron number and size in prefrontal cortex of children with autism. JAMA 306:2001-10
80. Fogel BL, Wexler E, Wahnich A, Friedrich T, Vijayendran C, et al. 2012. RBFOX1 regulates both splicing and transcriptional networks in human neuronal development. Hum. Mol. Genet. 21:4171-86
81. Eran A, Li JB, Vatalaro K, McCarthy J, Rahimov F, et al. 2013. Comparative RNA editing in autistic and neurotypical cerebella. Mol. Psychiatry 18:1041-48
82. Schain RJ, Yannet H. 1960. Infantile autism: an analysis of 50 cases and a consideration of certain relevant neurophysiologic concepts. J. Pediatr. 57:560-67
83. Bauman M, Kemper TL. 1985. Histoanatomic observations of the brain in early infantile autism. Neurology 35:866-66
84. Kemper TL, Bauman ML. 1993. The contribution of neuropathologic studies to the understanding of autism. Neurol. Clin. 11:175-87
85. Simms M, Kemper T, Timbie C, Bauman M, Blatt G. 2009. The anterior cingulate cortex in autism: heterogeneity of qualitative and quantitative cytoarchitectonic features suggests possible subgroups. Acta Neuropathol. 118:673-84
86. Bailey A, Luthert P, Dean A, Harding B, Janota I, et al. 1998. A clinicopathological study of autism. Brain 121:889-905
87. Schumann CM, Amaral DG. 2006. Stereological analysis of amygdala neuron number in autism. J. Neurosci. 26:7674-79
88. Raymond GV, Bauman ML, Kemper TL. 1995. Hippocampus in autism: a Golgi analysis. Acta Neuropathol. 91:117-19
89. Lawrence YA, Kemper TL, Bauman ML, Blatt GJ. 2010. Parvalbumin-, calbindin-, and calretininimmunoreactive hippocampal interneuron density in autism. Acta Neurol. Scand. 121:99-108
90. Wegiel J, Kuchna I, Nowicki K, Imaki H, Wegiel J, et al. 2010. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol. 119:755-70
91. Rutishauser U, Tudusciuc O, Wang S, Mamelak AN, Ross IB, Adolphs R. 2013. Single-neuron correlates of atypical face processing in autism. Neuron 80:887-99
92. Haznedar MM, Buchsbaum MS, Wei TC, Hof PR, Cartwright C, et al. 2000. Limbic circuitry in patients with autism spectrum disorders studied with positron emission tomography and magnetic resonance imaging. Am. J. Psychiatry 157:1994-2001
93. Fatemi SH, Aldinger K, Ashwood P, Bauman M, Blaha C, et al. 2012. Consensus paper: pathological role of the cerebellum in autism. Cerebellum 11:777-807
94. Whitney E, Kemper T, Bauman M, Rosene D, Blatt G. 2008. Cerebellar Purkinje cells are reduced in a subpopulation of autistic brains: a stereological experiment using calbindin-D28k. Cerebellum 7:406-16
95. Kemper TL, Bauman M. 1998. Neuropathology of infantile autism. J. Neuropathol. Exp. Neurol. 57:645-52
96. Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA. 2005. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 57:67-81
97. Sajdel-Sulkowska E, Xu M, Koibuchi N. 2009. Increase in cerebellar neurotrophin-3 and oxidative stress markers in autism. Cerebellum 8:366-72
98. Sheikh AM, Li X, Wen G, Tauqeer Z, Brown WT, Malik M. 2010. Cathepsin D and apoptosis related proteins are elevated in the brain of autistic subjects. Neuroscience 165:363-70
99. Whitney ER, Kemper TL, Rosene DL, Bauman ML, Blatt GJ. 2009. Density of cerebellar basket and stellate cells in autism: evidence for a late developmental loss of Purkinje cells. J. Neurosci. Res. 87:2245-54
100. Fournier K, Hass C, Naik S, Lodha N, Cauraugh J. 2010. Motor coordination in autism spectrum disorders: a synthesis and meta-Analysis. J. Autism Dev. Disord. 40:1227-40
101. Strick PL, Dum RP, Fiez JA. 2009. Cerebellum and nonmotor function. Annu. Rev. Neurosci. 32:413-34
102. Courchesne E, Townsend J, Akshoomoff NA, Saitoh O, Yeung-Courchesne R, et al. 1994. Impairment in shifting attention in autistic and cerebellar patients. Behav. Neurosci. 108:848-65
103. Coleman P, Romano J, Lapham L, Simon W. 1985. Cell counts in cerebral cortex of an autistic patient. J. Autism Dev. Disord. 15:245-55
104. Guerin P, Lyon G, Barthelemy C, Sostak E, Chevrollier V, et al. 1996. Neuropathological study of a case of autistic syndrome with severe mental retardation. Dev. Med. Child Neurol. 38:203-11
105. Hutsler JJ, Love T, Zhang H. 2007. Histological and magnetic resonance imaging assessment of cortical layering and thickness in autism spectrum disorders. Biol. Psychiatry 61:449-57
106. Oblak AL, Rosene DL, Kemper TL, Bauman ML, Blatt GJ. 2011. Altered posterior cingulate cortical cyctoarchitecture, but normal density of neurons and interneurons in the posterior cingulate cortex and fusiform gyrus in autism. Autism Res. 4:200-11
107. van Kooten IAJ, Palmen SJMC, von Cappeln P, Steinbusch HWM, Korr H, et al. 2008. Neurons in the fusiform gyrus are fewer and smaller in autism. Brain 131:987-99
108. Uppal N, Gianatiempo I, Wicinski B, Schmeidler J, Heinsen H, et al. 2014. Neuropathology of the posteroinferior occipitotemporal gyrus in children with autism. Mol. Autism 5:17
109. Mukaetova-Ladinska EB, Arnold H, Jaros E, Perry R, Perry E. 2004. Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals. Neuropathol. Appl. Neurobiol. 30:615-23
110. Casanova MF, Buxhoeveden DP, Switala AE, Roy E. 2002. Minicolumnar pathology in autism. Neurology 58:428-32
111. Buxhoeveden DP, Semendeferi K, Buckwalter J, Schenker N, Switzer R, Courchesne E. 2006. Reduced minicolumns in the frontal cortex of patients with autism. Neuropathol. Appl. Neurobiol. 32:483-91
112. Casanova MF, El-Baz A, Vanbogaert E, Narahari P, Switala A. 2010. A topographic study of minicolumnar core width by lamina comparison between autistic subjects and controls: possible minicolumnar disruption due to an anatomical element in-common to multiple laminae. Brain Pathol. 20:451-58
113. Hutsler JJ, Zhang H. 2010. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Res. 1309:83-94
114. Stoner R, Chow ML, Boyle MP, Sunkin SM, Mouton PR, et al. 2014. Patches of disorganization in the neocortex of children with autism. N. Engl. J. Med. 370:1209-19
115. Morgan JT, Chana G, Pardo CA, Achim C, Semendeferi K, et al. 2010. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 68:368-76
116. Tetreault N, Hakeem A, Jiang S, Williams B, Allman E, et al. 2012. Microglia in the cerebral cortex in autism. J. Autism Dev. Disord. 42:2569-84
117. Suzuki K, Sugihara G, Ouchi Y, Nakamura K, Futatsubashi M, et al. 2013. Microglial activation in young adults with autism spectrum disorder. JAMA Psychiatry 70:49-58
118. Rodriguez JI, Kern JK. 2011. Evidence of microglial activation in autism and its possible role in brain underconnectivity. Neuron Glia Biol. 7:205-13
119. Bailey A, Luthert P, Bolton P, Le Couteur A, Rutter M, Harding B. 1993. Autism and megalencephaly. Lancet 341:1225-26
120. Lainhart JE, Piven J, Wzorek M, Landa R, Santangelo SL, et al. 1997. Macrocephaly in children and adults with autism. J. Am. Acad. Child Adolesc. Psychiatry 36:282-90
121. Aylward EH, Minshew N, Field K, Sparks B, Singh N. 2002. Effects of age on brain volume and head circumference in autism. Neurology 59:175-83
122. Courchesne E, Carper R, Akshoomoff N. 2003. Evidence of brain overgrowth in the first year of life in autism. JAMA 290:337-44
123. Vanderver A, Tonduti D, Kahn I, Schmidt J, Medne L, et al. 2014. Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations. Am. J. Med. Genet. A 164:627-33
124. Courchesne E, M uller RA, Saitoh O. 1999. Brain weight in autism: normal in the majority of cases, megalencephalic in rare cases. Neurology 52:1057-59
125. Piven J, Arndt S, Bailey J, Havercamp S, Andreasen NC, Palmer P. 1995. An MRI study of brain size in autism. Am. J. Psychiatry 152:1145-49
126. Hardan AY, Minshew NJ, Mallikarjuhn M, Keshavan MS. 2001. Brain volume in autism. J. Child Neurol. 16:421-24
127. Hazlett HC, Poe MD, Gerig G, Smith RG, Piven J. 2006. Cortical gray and white brain tissue volume in adolescents and adults with autism. Biol. Psychiatry 59:1-6
128. Freitag CM, Luders E, Hulst HE, Narr KL, Thompson PM, et al. 2009. Total brain volume and corpus callosum size in medication-naive adolescents and young adults with autism spectrum disorder. Biol. Psychiatry 66:316-19
129. Courchesne E, Karns C, Davis H, Ziccardi R, Carper R, et al. 2001. Unusual brain growth patterns in early life in patients with autistic disorder an MRI study. Neurology 57:245-54
130. Redcay E, Courchesne E. 2005. When is the brain enlarged in autism?. A meta-Analysis of all brain size reports. Biol. Psychiatry 58:1-9
131. Hazlett H, PoeM, Gerig G, Smith RG, Provenzale J, et al. 2005. Magnetic resonance imaging and head circumference study of brain size in autism: birth through age 2 years. Arch. Gen. Psychiatry 62:1366-76
132. Carper RA, Courchesne E. 2005. Localized enlargement of the frontal cortex in early autism. Biol. Psychiatry 57:126-33
133. Stanfield AC, McIntosh AM, Spencer MD, Philip R, Gaur S, Lawrie SM. 2008. Towards a neuroanatomy of autism: a systematic review and meta-Analysis of structural magnetic resonance imaging studies. Eur. Psychiatry 23:289-99
134. Rojas D, Peterson E, Winterrowd E, Reite M, Rogers S, Tregellas J. 2006. Regional gray matter volumetric changes in autism associated with social and repetitive behavior symptoms. BMC Psychiatry 6:1-13
135. Schumann CM, Hamstra J, Goodlin-Jones BL, Lotspeich LJ, Kwon H, et al. 2004. The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J. Neurosci. 24:6392-401
136. Courchesne E, Yeung-Courchesne R, Hesselink JR, Jernigan TL. 1988. Hypoplasia of cerebellar vermal lobules VI and VII in autism. N. Engl. J. Med. 318:1349-54
137. Just MA, Cherkassky VL, Keller TA, Kana RK, Minshew NJ. 2007. Functional and anatomical cortical underconnectivity in autism: evidence from an fMRI study of an executive function task and corpus callosum morphometry. Cereb. Cortex 17:951-61
138. Nickl-Jockschat T, Habel U, Michel TM, Manning J, Laird AR, et al. 2012. Brain structure anomalies in autism spectrum disorder-A meta-Analysis of VBM studies using anatomic likelihood estimation. Hum. Brain Mapp. 33:1470-89
139. McAlonan GM, Cheung V, Cheung C, Suckling J, Lam GY, et al. 2005. Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain 128:268-76
140. Yachnis AT, Rorke LB. 1999. Neuropathology of Joubert syndrome. J. Child Neurol. 14:655-59
141. Armstrong DD. 2002. Neuropathology of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 8:72-76
142. Mizuguchi M, Takashima S. 2001. Neuropathology of tuberous sclerosis. Brain Dev. 23:508-15
143. Chadman KK, Yang M, Crawley JN. 2009. Criteria for validating mouse models of psychiatric diseases. Am. J. Med. Genet. B 150B:1-11
144. Nestler EJ, Hyman SE. 2010. Animal models of neuropsychiatric disorders. Nat. Neurosci. 13:1161-69
145. Crawley JN. 2007. Mouse behavioral assays relevant to the symptoms of autism. Brain Pathol. 17:448-59
146. Pe nagarikano O, Abrahams BS, Herman EI, Winden KD, Gdalyahu A, et al. 2011. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 147:235-46
147. Schmeisser MJ, Ey E, Wegener S, Bockmann J, Stempel AV, et al. 2012. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 486:256-60
148. Peca J, Feliciano C, Ting JT, Wang W, Wells MF, et al. 2011. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472:437-42
149. Smith SE, Zhou YD, Zhang G, Jin Z, Stoppel DC, Anderson MP. 2011. Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice. Sci. Transl.Med. 3:103ra97
150. Moy SS, Nadler JJ, Young NB, Perez A, Holloway LP, et al. 2007. Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains. Behav. Brain Res. 176:4-20
151. Wagner G, Reuhl K, Cheh M, McRae P, Halladay A. 2006. A new neurobehavioral model of autism in mice: pre-And postnatal exposure to sodium valproate. J. Autism Dev. Disord. 36:779-93
152. Zerbo O, Qian Y, Yoshida C, Grether JK, Van de Water J, Croen LA. 2013. Maternal infection during pregnancy and autism spectrum disorders. J. Autism Dev. Disord. In press. doi: 10.1007/s10803-013-2016-3
153. Harris KM. 1999. Structure, development, and plasticity of dendritic spines. Curr. Opin. Neurobiol. 9:343-48
154. Zoghbi HY. 2003. Postnatal neurodevelopmental disorders: meeting at the synapse?. Science 302:826-30
155. Jamain S, Radyushkin K, Hammerschmidt K, Granon S, Boretius S, et al. 2008. Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. PNAS 105:1710-15
156. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, et al. 2007.Aneuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318:71-76
157. Etherton M, Foldy C, Sharma M, Tabuchi K, Liu X, et al. 2011. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. PNAS 108:13764-69
158. Phelan K, McDermid HE. 2012. The 22q13.3 deletion syndrome (Phelan-McDermid syndrome). Mol. Syndromol. 2:186-201
159. Scott-Van Zeeland AA, Abrahams BS, Alvarez-Retuerto AI, Sonnenblick LI, Rudie JD, et al. 2010. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci. Transl. Med. 2:56ra80
160. Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, et al. 2010. Haploinsufficiency of the autism-Associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol. Autism 1:15
161. Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, et al. 2011. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum. Mol. Genet. 20:3093-108
162. Won H, Lee HR, Gee HY, MahW, Kim JI, et al. 2012. Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486:261-65
163. Poliak S, Salomon D, Elhanany H, Sabanay H, Kiernan B, et al. 2003. Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J. Cell Biol. 162:1149-60
164. Huber KM, Gallagher SM, Warren ST, Bear MF. 2002. Altered synaptic plasticity in a mouse model of fragile X mental retardation. PNAS 99:7746-50
165. Bear MF, Huber KM, Warren ST. 2004. The mGluR theory of fragile X mental retardation. Trends Neurosci. 27:370-77
166. Nosyreva ED, Huber KM. 2006. Metabotropic receptor-dependent long-Term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. J. Neurophysiol. 95:3291-95
167. Irwin SA, Galvez R, Greenough WT. 2000. Dendritic spine structural anomalies in fragile-X mental retardation syndrome. Cereb. Cortex 10:1038-44
168. Dolen G, Osterweil E, Rao BS, Smith GB, Auerbach BD, et al. 2007. Correction of fragile X syndrome in mice. Neuron 56:955-62
169. El Idrissi A, Ding XH, Scalia J, Trenkner E, Brown WT, Dobkin C. 2005. Decreased GABAA receptor expression in the seizure-prone fragile X mouse. Neurosci. Lett. 377:141-46
170. D'Hulst C, De Geest N, Reeve SP, Van Dam D, De Deyn PP, et al. 2006. Decreased expression of the GABAA receptor in fragile X syndrome. Brain Res. 1121:238-45
171. Selby L, Zhang C, Sun QQ. 2007. Major defects in neocortical GABAergic inhibitory circuits in mice lacking the fragile X mental retardation protein. Neurosci. Lett. 412:227-32
172. Sadakata T, Furuichi T. 2009. Developmentally regulated Ca2+-dependent activator protein for secretion 2 (CAPS2) is involved in BDNF secretion and is associated with autism susceptibility. Cerebellum 8:312-22
173. Gharani N, Benayed R, Mancuso V, Brzustowicz LM, Millonig JH. 2004. Association of the homeobox transcription factor, ENGRAILED 2, 3, with autism spectrum disorder. Mol. Psychiatry 9:474-84
174. Kuemerle B, Zanjani H, Joyner A, Herrup K. 1997. Pattern deformities and cell loss in Engrailed-2 mutant mice suggest two separate patterning events during cerebellar development. J. Neurosci. 17:7881-89
175. Sgado P, Genovesi S, Kalinovsky A, Zunino G, Macchi F, et al. 2013. Loss of GABAergic neurons in the hippocampus and cerebral cortex of Engrailed-2 null mutant mice: implications for autism spectrum disorders. Exp. Neurol. 247:496-505
176. Stiles BL. 2009. Phosphatase and tensin homologue deleted on chromosome 10: extending its PTENtacles. Int. J. Biochem. Cell Biol. 41:757-61
177. Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, et al. 2006. Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377-88
178. Zhou J, Blundell J, Ogawa S, Kwon CH, Zhang W, et al. 2009. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J. Neurosci. 29:1773-83
179. Luikart BW, Schnell E, Washburn EK, Bensen AL, Tovar KR, Westbrook GL. 2011. Pten knockdown in vivo increases excitatory drive onto dentate granule cells. J. Neurosci. 31:4345-54
180. Haws ME, Jaramillo TC, Espinosa F, Widman AJ, Stuber GD, et al. 2014. PTEN knockdown alters dendritic spine/protrusion morphology, not density. J. Comp. Neurol. 522:1171-90
181. Eluvathingal TJ, Behen ME, Chugani HT, Janisse J, Bernardi B, et al. 2006. Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates. J. Child Neurol. 21:846-51
182. Tsai PT, Hull C, Chu Y, Greene-Colozzi E, Sadowski AR, et al. 2012. Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice. Nature 488:647-51
183. Reith RM, McKenna J, WuH, Hashmi SS, Cho SH, et al. 2013. Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex. Neurobiol. Dis. 51:93-103
184. Auerbach BD, Osterweil EK, Bear MF. 2011. Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480:63-68
185. Talkowski ME, Rosenfeld JA, Blumenthal I, Pillalamarri V, Chiang C, et al. 2012. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell 149:525-37
186. Wang IT, Allen M, Goffin D, Zhu X, Fairless AH, et al. 2012. Loss of CDKL5 disrupts kinome profile and event-related potentials leading to autistic-like phenotypes in mice. PNAS 109:21516-21
187. Anderson GM, Horne WC, Chatterjee D, Cohen DJ. 1990. The hyperserotonemia of autism. Ann. N.Y. Acad. Sci. 600:331-40; discussion 41-42
188. Cook EH, Leventhal BL. 1996. The serotonin system in autism. Curr. Opin. Pediatr. 8:348-54
189. Azmitia EC. 2007. Serotonin and brain: evolution, neuroplasticity, and homeostasis. Int. Rev. Neurobiol. 77:31-56
190. Kim SJ, Cox N, Courchesne R, Lord C, Corsello C, et al. 2002. Transmission disequilibrium mapping at the serotonin transporter gene (SLC6A4) region in autistic disorder. Mol. Psychiatry 7:278-88
191. Conroy J, Meally E, Kearney G, Fitzgerald M, Gill M, Gallagher L. 2004. Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population. Mol. Psychiatry 9:587-93
192. Cohen IL, Liu X, Schutz C, White BN, Jenkins EC, et al. 2003. Association of autism severity with a monoamine oxidase A functional polymorphism. Clin. Genet. 64:190-97
193. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, et al. 2003. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol. Psychiatry 54:960-71
194. Veenstra-VanderWeele J, Muller CL, Iwamoto H, Sauer JE, Owens WA, et al. 2012. Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior. PNAS 109:5469-74
195. Bortolato M, Godar SC, Alzghoul L, Zhang J, Darling RD, et al. 2013. Monoamine oxidase A and A/B knockout mice display autistic-like features. Int. J. Neuropsychopharmacol. 16:869-88
196. Wassink TH, Piven J, Vieland VJ, Pietila J, Goedken RJ, et al. 2004. Examination of AVPR1a as an autism susceptibility gene. Mol. Psychiatry 9:968-72
197. Lerer E, Levi S, Salomon S, Darvasi A, Yirmiya N, Ebstein RP. 2008. Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition. Mol. Psychiatry 13:980-88
198. Munesue T, Yokoyama S, Nakamura K, Anitha A, Yamada K, et al. 2010. Two genetic variants of CD38 in subjects with autism spectrum disorder and controls. Neurosci. Res. 67:181-91
199. Ross HE, Young LJ. 2009. Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Front. Neuroendocrinol. 30:534-47
200. Takayanagi Y, Yoshida M, Bielsky IF, Ross HE, Kawamata M, et al. 2005. Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice. PNAS 102:16096-101
201. Higashida H, Yokoyama S, Munesue T, Kikuchi M, Minabe Y, Lopatina O. 2011. Cd38 gene knockout juvenile mice: a model of oxytocin signal defects in autism. Biol. Pharm. Bull. 34:1369-72
202. Ferguson JN, Aldag JM, Insel TR, Young LJ. 2001. Oxytocin in the medial amygdala is essential for social recognition in the mouse. J. Neurosci. 21:8278-85
203. Jin D, Liu HX, Hirai H, Torashima T, Nagai T, et al. 2007. CD38 is critical for social behaviour by regulating oxytocin secretion. Nature 446:41-45
204. Sala M, Braida D, Lentini D, Busnelli M, Bulgheroni E, et al. 2011. Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism. Biol. Psychiatry 69:875-82
205. Egashira N, Tanoue A, Matsuda T, Koushi E, Harada S, et al. 2007. Impaired social interaction and reduced anxiety-related behavior in vasopressin V1a receptor knockout mice. Behav. Brain Res. 178:123-27
206. Ring RH. 2011. A complicated picture of oxytocin action in the central nervous system revealed. Biol. Psychiatry 69:818-19
207. Verkhratsky A. 2010. Physiology of neuronal-glial networking. Neurochem. Int. 57:332-43
208. Pekny M, Wilhelmsson U, Pekna M. 2014. The dual role of astrocyte activation and reactive gliosis. Neurosci. Lett. 565:30-38
209. Frick LR, Williams K, Pittenger C. 2013. Microglial dysregulation in psychiatric disease. Clin. Dev. Immunol. 2013:608654
210. Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, et al. 2014. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nat. Neurosci. 17:400-6
211. Geschwind DH. 2008. Autism: many genes, common pathways?. Cell 135:391-95
212. Geschwind DH, Konopka G. 2009. Neuroscience in the era of functional genomics and systems biology. Nature 461:908-15
213. Ben-David E, Shifman S. 2012. Networks of neuronal genes affected by common and rare variants in autism spectrum disorders. PLOS Genet. 8:e1002556
214. Gilman SR, Iossifov I, Levy D, Ronemus M, Wigler M, Vitkup D. 2011. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron 70:898-907
215. Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, et al. 2013. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155:997-1007
216. Parikshak NN, Luo R, Zhang A, Won H, Lowe JK, et al. 2013. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155:1008-21
217. Steinberg J, Webber C. 2013. The roles of FMRP-regulated genes in autism spectrum disorder: singleand multiple-hit genetic etiologies. Am. J. Hum. Genet. 93:825-39
218. Dolmetsch R, Geschwind DH. 2011. The human brain in a dish: the promise of iPSC-derived neurons. Cell 145:831-34
219. Geschwind DH, Levitt P. 2007. Autism spectrum disorders: developmental disconnection syndromes. Curr. Opin. Neurobiol. 17:103-11
220. Courchesne E, Pierce K. 2005. Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr. Opin. Neurobiol. 15:225-30
221. Casanova M, Kooten IJ, Switala A, Engeland H, Heinsen H, et al. 2006. Minicolumnar abnormalities in autism. Acta Neuropathol. 112:287-303
222. Assaf M, Jagannathan K, Calhoun VD, Miller L, Stevens MC, et al. 2010. Abnormal functional connectivity of default mode sub-networks in autism spectrum disorder patients. NeuroImage 53:247-56
223. Koshino H, Carpenter PA, Minshew NJ, Cherkassky VL, Keller TA, Just MA. 2005. Functional connectivity in an fMRI working memory task in high-functioning autism. NeuroImage 24:810-21
224. Just MA, Keller TA, Malave VL, Kana RK, Varma S. 2012. Autism as a neural systems disorder: a theory of frontal-posterior underconnectivity. Neurosci. Biobehav. Rev. 36:1292-313
225. Kleinhans NM, Richards T, Sterling L, Stegbauer KC, Mahurin R, et al. 2008. Abnormal functional connectivity in autism spectrum disorders during face processing. Brain 131:1000-12
226. Di Martino A, Kelly C, Grzadzinski R, Zuo XN, Mennes M, et al. 2011. Aberrant striatal functional connectivity in children with autism. Biol. Psychiatry 69:847-56
227. Turner KC, Frost L, Linsenbardt D, McIlroy JR, M uller R. 2006. Atypically diffuse functional connectivity between caudate nuclei and cerebral cortex in autism. Behav. Brain Funct. 2:34
228. Anderson JS, Druzgal TJ, Froehlich A, DuBray MB, Lange N, et al. 2011. Decreased interhemispheric functional connectivity in autism. Cereb. Cortex 21:1134-46
229. Courchesne E, Pierce K. 2005. Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int. J. Dev. Neurosci. 23:153-70
230. Ebert DH, Greenberg ME. 2013. Activity-dependent neuronal signalling and autism spectrum disorder. Nature 493:327-37
231. Ben-David E, Shifman S. 2013. Combined analysis of exome sequencing points toward a major role for transcription regulation during brain development in autism. Mol. Psychiatry 18:1054-56
232. Fatemi SH, Folsom T, Kneeland R, Yousefi M, Liesch S, Thuras P. 2013. Impairment of fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling and its downstream cognates ras-related C3 botulinum toxin substrate 1, amyloid beta A4 precursor protein, striatal-enriched protein tyrosine phosphatase, and homer 1, in autism: a postmortem study in cerebellar vermis and superior frontal cortex. Mol. Autism 4:21
233. Silverman JL, Tolu SS, Barkan CL, Crawley JN. 2009. Repetitive self-grooming behavior in the BTBR mousemodel of autism is blocked by the mGluR5 antagonistMPEP. Neuropsychopharmacology 35:976-89
234. Mehta MV, Gandal MJ, Siegel SJ. 2011. mGluR5-Antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism. PLOS ONE 6:e26077
235. Dolan BM, Duron SG, Campbell DA, Vollrath B, Rao BSS, et al. 2013. Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486. PNAS 110:5671-76
236. Han S, Tai C, Jones CJ, Scheuer T, Catterall WA. 2014. Enhancement of inhibitory neurotransmission by GABAA receptors having α2, 3-subunits ameliorates behavioral deficits in a mouse model of autism. Neuron 81:1282-89
237. Buchovecky CM, Turley SD, Brown HM, Kyle SM, McDonald JG, et al. 2013. A suppressor screen in Mecp2 mutant mice implicates cholesterol metabolism in Rett syndrome. Nat. Genet. 45:1013-20
238. Levitt JG, Blanton RE, Smalley S, Thompson PM, Guthrie D, et al. 2003. Cortical sulcal maps in autism. Cereb. Cortex 13:728-35
239. Weinstein M, Ben-Sira L, Levy Y, Zachor DA, Itzhak EB, et al. 2011. Abnormal white matter integrity in young children with autism. Hum. Brain Mapp. 32:534-43
240. Shukla DK, Keehn B, M uller RA. 2011. Tract-specific analyses of diffusion tensor imaging show widespread white matter compromise in autism spectrum disorder. J. Child Psychol. Psychiatry 52:286-95
241. Rudie JD, Hernandez LM, Brown JA, Beck-Pancer D, Colich NL, et al. 2012. Autism-Associated promoter variant in MET impacts functional and structural brain networks. Neuron 75:904-15
242. Ecker C, Ronan L, Feng Y, Daly E, Murphy C, et al. 2013. Intrinsic gray-matter connectivity of the brain in adults with autism spectrum disorder. PNAS 110:13222-27
243. Murias M, Webb SJ, Greenson J, Dawson G. 2007. Resting state cortical connectivity reflected in EEG coherence in individuals with autism. Biol. Psychiatry 62:270-73
244. Koshino H, Kana RK, Keller TA, Cherkassky VL, Minshew NJ, Just MA. 2008. fMRI investigation of working memory for faces in autism: visual coding and underconnectivity with frontal areas. Cereb. Cortex 18:289-300
245. Di Martino A, Yan CG, Li Q, Denio E, Castellanos FX, et al. 2014. The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism. Mol. Psychiatry 19:659-67
246. Khan S, Gramfort A, Shetty NR, Kitzbichler MG, Ganesan S, et al. 2013. Local and long-range functional connectivity is reduced in concert in autism spectrum disorders. PNAS 110:3107-12
247. Bader PL, Faizi M, Kim LH, Owen SF, Tadross MR, et al. 2011. Mouse model of Timothy syndrome recapitulates triad of autistic traits. PNAS 108:15432-37
248. Irie F, Badie-MahdaviH, Yamaguchi Y. 2012. Autism-like socio-communicative deficits and stereotypies in mice lacking heparan sulfate. PNAS 109:5052-56
249. Jiang M, Ash RT, Baker SA, Suter B, Ferguson A, et al. 2013. Dendritic arborization and spine dynamics are abnormal in the mouse model of MECP2 duplication syndrome. J. Neurosci. 33:19518-33
250. Etherton MR, Blaiss CA, Powell CM, S udhof TC. 2009. Mouse neurexin-1αdeletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. PNAS 106:17998-8003
251. Han S, Tai C, Westenbroek RE, Yu FH, Cheah CS, et al. 2012. Autistic-like behaviour in Scn1a+/-mice and rescue by enhanced GABA-mediated neurotransmission. Nature 489:385-90
252. Ehninger D, Han S, Shilyansky C, Zhou Y, LiW, et al. 2008. Reversal of learning deficits in a Tsc2+/-mouse model of tuberous sclerosis. Nat. Med. 14:843-48
253. Winslow JT, Insel TR. 2002. The social deficits of the oxytocin knockout mouse. Neuropeptides 36:221-29
254. Carter MD, Shah CR, Muller CL, Crawley JN, Carneiro AMD, Veenstra-Vander Weele J. 2011. Absence of preference for social novelty and increased grooming in integrin β3 knockout mice: initial studies and future directions. Autism Res. 4:57-67
255. Gunn RK, Huentelman MJ, Brown RE. 2011. Are Sema5a mutant mice a good model of autism?. A behavioral analysis of sensory systems, emotionality and cognition. Behav. Brain Res. 225:142-50
256. Oguro-Ando A, Rosensweig C, Herman E, Nishimura Y, Werling D, et al. 2014. Increased CYFIP1 dosage alters cellular and dendritic morphology and dysregulates mTOR. Mol. Psychiatry. doi: 10.1038/mp.2014.124